Skip to main content
Equibles

VISTN · VISTIN PHARMA ASA · Investor Relations

Use VISTN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VISTN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
18.1000 NOK 15-min delayed · Oct 9, 09:12 UTC
Rebalance outlook locked
Market Cap
811.51M NOK
Shares
44.34M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-12-02 00:00 UTC Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend Event

Past events

Date Event Type
2026-08-20 Vistin Pharma ASA: Second quarter and YTD 2026 financial results Results publication
2026-08-13 Vistin Pharma ASA: Invitation to Q2 2026 conference call Earnings call
2026-05-22 Ex dividend NOK 1.00 today Event
2026-05-20 Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 Shareholder meeting
2026-05-20 Vistin Pharma ASA: Minutes from the annual general meeting 2026 Shareholder meeting
2026-05-20 Disclosure of voting rights at AGM in Vistin Pharma ASA Event
2026-04-28 Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 Shareholder meeting
2026-04-24 Vistin Pharma ASA: First quarter 2026 financial results Results publication
2026-04-24 2025 Annual Report Vistin Pharma ASA Event
2026-04-17 Vistin Pharma ASA: Invitation to Q1 2026 conference call Earnings call
2026-02-20 Vistin Pharma ASA: Mandatory notification of trade Event
2026-02-12 Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend Event
2026-02-12 Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results Results publication
2026-02-05 Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call Earnings call
2025-10-31 Vistin Pharma ASA: Third quarter and YTD 2025 financial results Results publication
2025-10-24 Vistin Pharma ASA: Invitation to Q3 2025 conference call Earnings call
2025-08-15 Vistin Pharma ASA: Second quarter and YTD 2025 financial results Results publication
2025-08-08 Vistin Pharma ASA: Invitation to Q2 2025 conference call Earnings call
2025-07-05 Vistin Pharma ASA (VISTN): Update from the Election Committee Event
2025-06-05 Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding Event
2025-06-04 Ex dividend NOK 1.25 today Event
2025-05-22 Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025 Shareholder meeting
2025-05-22 Vistin Pharma ASA: Minutes from the annual general meeting 2025 Shareholder meeting
2025-05-22 Disclosure of voting rights at AGM in Vistin Pharma ASA Event
2025-05-07 Vistin Pharma ASA (VISTN): Update from the Election Committee Event

Source: https://www.vistin.com/investors